Nyxoah Annonce la Clôture de l’Offre et l’Exercice Partiel de l’Option d’Achat d’Actions Supplémentaires
May 31, 2024 02:00 ET
|
Nyxoah
INFORMATIONS PRIVILÉGIÉESINFORMATIONS RÉGLEMENTÉES Nyxoah Annonce la Clôture de l’Offre et l’Exercice Partiel de l’Option d’Achat d’Actions Supplémentaires Mont-Saint-Guibert, Belgique –...
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
May 31, 2024 02:00 ET
|
Nyxoah
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Closing of Offering and Partial Exercise ofOption to Purchase Additional Shares Mont-Saint-Guibert, Belgium – May 31, 2024, 8:00am CET /...
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC regarding Pending Legal Proceeding
May 31, 2024 01:30 ET
|
Baosheng Media Group Holdings Limited
Beijing, China, May 31, 2024 (GLOBE NEWSWIRE) -- Baosheng Media Group Holdings Limited (NASDAQ: BAOS) (“Baosheng” or the “Company”), a China-based online marketing solution provider, today announced...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
May 31, 2024 01:05 ET
|
Regeneron Pharmaceuticals, Inc.
Recommendation for adults with uncontrolled COPD with raised blood eosinophils based on data from two landmark Phase 3 trials demonstrating Dupixent significantly reduced exacerbations and improved...
VEON discloses April YTD trading update at its AGM
May 31, 2024 01:00 ET
|
VEON Ltd.
VEON discloses April YTD trading update at its AGM Amsterdam, 31 May 2024 07:00 CEST – VEON April YTD 2024 Highlights Total revenue of USD 1,278 million, +8.6% YoY (+12.9% YoY in local...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type 2 Inflammation
May 31, 2024 01:00 ET
|
Regeneron Pharmaceuticals, Inc.
TARRYTOWN, N.Y. and PARIS, May 31, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by...
United States Government to Reinstate Section 301 Import Tariffs on Artificial Graphite from China
May 30, 2024 21:41 ET
|
Novonix Ltd.
BRISBANE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today applauded the recent announcement...
Pineapple Energy Announces Appointment of Chief Operating Officer
May 30, 2024 20:19 ET
|
Pineapple Energy
Pineapple Energy Announces Appointment of Chief Operating Officer
San Diego County Regional Public Safety Agencies Launch Genasys EVAC for Enhanced Emergency Communication
May 30, 2024 19:36 ET
|
Genasys Inc.
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in Protective Communications, is pleased to announce that the San Diego County regional area announced...
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
May 30, 2024 18:05 ET
|
Jasper Therapeutics, Inc.
REDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...